Cargando…
Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays
Pharmacologic inhibition of the protein-protein interaction (PPI) interface of the Keap1:Nrf2 complex, which leads to Nrf2 activation and cytoprotective gene expression, offers a promising strategy for disease prevention and treatment. To facilitate identification and validation of small-molecule Ke...
Autores principales: | Dayalan Naidu, Sharadha, Dikovskaya, Dina, Moore, Terry W., Dinkova-Kostova, Albena T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980889/ https://www.ncbi.nlm.nih.gov/pubmed/35391936 http://dx.doi.org/10.1016/j.xpro.2022.101265 |
Ejemplares similares
-
KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2020) -
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2021) -
Phenyl Bis-Sulfonamide
Keap1-Nrf2 Protein–Protein
Interaction Inhibitors with an Alternative Binding Mode
por: Georgakopoulos, Nikolaos, et al.
Publicado: (2022) -
C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2018) -
Phenethyl Isothiocyanate, a Dual Activator of Transcription Factors NRF2 and HSF1
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2018)